Long Term Use of Inhaled Anticholinergic Agents in Chronic Obstructive Pulmonary Disease Patients Does Not Increase the Risk of Cardiovascular Events: A Meta-analysis of Randomized Controlled Trials

被引：0
|
作者：
Katragadda, Srikanth
Molnar, Janos
Arora, Rohit R.
机构：
[1] Mercy St Vincent Med Cntr, Toledo, OH USA
[2] Finch Univ Hlth Sci Chicago Med Sch, N Chicago, IL 60064 USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Cardiovascular disease; Pulmonary;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13125
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Association of tiotropium use and the risk of adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials
    Yang, Mingjin
    Zhang, Yan
    Cheng, Hong
    Xu, Zhibo
    He, Jianqing
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (06) : 795 - 805
  • [2] Association of tiotropium use and the risk of adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials
    Mingjin Yang
    Yan Zhang
    Hong Cheng
    Zhibo Xu
    Jianqing He
    European Journal of Clinical Pharmacology, 2020, 76 : 795 - 805
  • [3] Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials
    Chen, Hong
    Sun, Jian
    Huang, Qiang
    Liu, Yongqi
    Yuan, Mengxin
    Ma, Chunlan
    Yan, Hao
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [4] Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials
    Yang, Mingjin
    Du, Yuejun
    Chen, Hong
    Jiang, Depeng
    Xu, Zhibo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 77
  • [5] Risk of Cardiovascular Events Associated with Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis
    Jing, Xia
    Li, Yufeng
    Xu, Jianying
    CANADIAN RESPIRATORY JOURNAL, 2018, 2018
  • [6] Risk of Tuberculosis and Influenza Associated with Use of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Dong, Yaa-Hui
    Chang, Chia-Hsuin
    Wu, Fe-Lin Lin
    Shen, Li-Jiuan
    Lofdahl, Claes-Goran
    Lai, Mei-Shu
    Mahler, Donald A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 48 - 48
  • [7] Long-term Use of Inhaled Corticosteroids and the Risk of Pneumonia in Chronic Obstructive Pulmonary Disease A Meta-analysis
    Singh, Sonal
    Amin, Aman V.
    Loke, Yoon K.
    ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (03) : 219 - 229
  • [8] Rehabilitation for patients with chronic obstructive pulmonary disease - Meta-analysis of randomized controlled trials
    Salman, GF
    Mosier, MC
    Beasley, BW
    Calkins, DR
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 (03) : 213 - 221
  • [9] Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease - A systematic review and meta-analysis
    Singh, Sonal
    Loke, Yoon K.
    Furberg, Curt D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (12): : 1439 - 1450
  • [10] Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials
    Vineet S. Rolston
    Jessica Kimmel
    Violeta Popov
    Brian P. Bosworth
    David Hudesman
    Lisa B. Malter
    Simon Hong
    Shannon Chang
    Digestive Diseases and Sciences, 2021, 66 : 1631 - 1638
12345